PipEracillin-Tazobactam versus mERoPENem for treatment of bloodstream infections caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN) – 371 024$ CAD
Principal Investigators: Lee TC, McDonald EG, Cheng MP
Co-candidates: Afra K, Bitterman R, Butler-Laporte G, Carignan A, Conly J, Grant J, Gregson D, Haljian G, Marsot A, Parkes L, Paul M, Somayaji R, Thirion D
Comments